Your browser doesn't support javascript.
loading
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Hamimed, Mourad; Devillier, Raynier; Weiller, Pierre-Jean; Marin, Clémence; Schiano, Jean-Marc; Belmecheri, Nawel; Etienne-Grimaldi, Marie-Christine; Ciccolini, Joseph; Harbi, Samia.
Affiliation
  • Hamimed M; SMARTc Unit, CRCM Inserm U1068, Aix Marseille Univ, Marseille, France.
  • Devillier R; COMPO, CRCM Inserm U1068 and INRIA Sophia Antipolis, Aix Marseille Univ, Marseille, France.
  • Weiller PJ; Hematology Unit, Paoli Calmettes Institute, Marseille, France.
  • Marin C; Hematology Unit, Paoli Calmettes Institute, Marseille, France.
  • Schiano JM; SMARTc Unit, CRCM Inserm U1068, Aix Marseille Univ, Marseille, France.
  • Belmecheri N; Clinical Pharmacokinetics Laboratory, La Timone University Hospital of Marseille, Marseille, France.
  • Etienne-Grimaldi MC; Hematology Unit, Paoli Calmettes Institute, Marseille, France.
  • Ciccolini J; Hematology Unit, Paoli Calmettes Institute, Marseille, France.
  • Harbi S; Oncopharmacology Unit, Centre Antoine Lacassagne, Nice, France.
Cancer Chemother Pharmacol ; 2023 Nov 13.
Article in En | MEDLINE | ID: mdl-37957436
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Chemother Pharmacol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancer Chemother Pharmacol Year: 2023 Document type: Article Affiliation country: Country of publication: